GSK in news
Enable javascript settings in browser
Novemeber 7
GSK Pharma Q3 Net Rises 4.44%, Economic Times
November 7
GSK Pharma Q3 profit up 4%, Hindu Business Line
August 14
GSK Profit Rises 12% in Q2 on Robust Indian Market, Economic Times
August 14
GSK Q2 net up 10.83%, Indian Express
August 14
Vaccines, skin products drive GSK net in Q2, Hindu Business Line
February 17
GlaxoSmithKline net grows 18% at Rs 136 cr, Financial Chronicle
February 17
GSK Pharmaceuticasl heads into a period of consolidation, Mint
February 17
Vaccines, cost cutting help boost GSK Pharma Q4 net, Hindu Business Line
July 23
GlaxoSmithKline launches two cancer drugs at reduced prices, Hindu Business Line
July 23
GSK's cancer drugs, Business Standard
July 23
Glaxo adds new drugs to cancer portfolio, Mint
May 7
GSK Pharma net down on one-time penalty provision, Hindu Business Line
May 7
Litigation, higher costs take a toll on GSK Pharma profits, Mint
March 30
It is not by Accident that Glaxo is Right on Top, Economic Times
March 24
Augmentin topples Corex as top seller, Times of India
February 15
Glaxo net at Rs 116 crore, Financial Chronicle
February 15
Glaxo Pharma profits up, Deccan Chronicle
February 15
GSK Pharma net up 10% at 560.6 crores, Business Standard
February 15
GSK Pharma pins hopes on new products, Mint
February 15
GSK Pharma to raise headcount to support product roll-out, Hindu Business Line
February 14
GSK wins the most Respected Pharma Company Award 2011, Business World
November 23
Hasit Joshipura interviewed on GSK's plans in India, PharmAsia
October 29
GSK Pharma Q3 net rises 12%, Hindu Business Line
October 29
Rise in sales, new launches boost GSK Net, Mint
July 27
GSK Net Profit up 3.7%, Business Standard
July 27
GSK Pharma sees vaccines supply improving; Q2 net profit rises 4%, Hindu Business Line
April 28
GSK Pharma plans more investments to support growth, Hindu Business Line
April 28
Product launches will be critical to GSK Pharma's future plans, Mint
April 28
Strong sales focus to help co do better than its peers, The Economic Times
March 12
GDP related pricing better for mankind, The Times of India - Nashik
March 11
CEO visit Glaxo's med outpost at Deonar dump, The Times of India
March 10
GSK to increase sales in Emerging Markets, Business Bhaskar - Hindi
March 10
GlaxoSmithKline stays confident on patent regime, Financial Express
March 10
GSK to lower prices to woo India mkt, The Economic Times
March 10
Our Indian operations are a great success story, Business Standard
March 10
We will cut drug prices by reducing production cost, The Economic Times
March 10
GSK back to differential price for drugs in mid-income nations, Hindu Business Line
March 10
We are actively looking at growing organically and inorganically, Mint
March 9
GSK scouting for acquistions, Business Standard - Hindi
March 9
Glaxo interested in Indian Acquisitions, Business Standard
March 9
Glaxo chief Witty says ready to ramp up play, DNA
February 16
GSK sees growth shot in vaccines, DNA
February 16
GSK to increase headcount, introduce more products, Hindu Business Line
February 16
GSK's new strategy brightens prospects, Mint
February 16
New product pipeline to boost sales, The Economic Times
July 29
New products help GSK post 8% growth in Q2 net, The Economic Times
June 22
Cover story - New Prescription, Business World
April 29
GSK Pharma Q1 profit at 18%, Financial Chronicle
April 29
Upbeat Glaxo Pharma plans new launches, acquisitions, Business Standard
April 6
GSK India will outpace industry growth, Business Standard (Smart Investor)
March 23
Vaccine to fight cervical cancer, Deccan Chronicle
February 19
Glaxo Pharma looking for domestic acquisition, Business Standard
February 19
GlaxoSmithKline Q4 profit at Rs. 208 crore, Financial Chronicle
February 19
GSK Pharma to increase field-force, The Hindu Business Line
November 17
Pop this growth pill, The Economic Times
November 14
Patenting Growth, Outlook Business
October 25
GSK's priority products, vaccines bolster performance, The Hindu Business Line
October 25
GlaxoSmithKline Q3 net profit at Rs. 132 crore, Mint
October 10
GSK tackles tropical disease with new facility, The New Indian Express
October 10
Glaxo's drive against filariasis, The Hindu Business Line
August 2
Looking Healthy, DNA
July 29
GlaxoSmithKline net up on cost optimisation, The Hindu Business Line
June 14
Vaccine for Rotavirus Diarrhoea coming soon, DNA
May 30
Glaxo starts India tests of breast cancer drug to expand its use, Mint
May 27
GSK to launch cancer drug at 25% discount, Business Standard
May 15
GSK to market Daiichi Sankyo drugs in India, Business Standard
May 15
GSK Inks Pact with Daiichi Sankyo for co-promotion of Drug, The Financial World
April 22
GSK pharma Q1 net jumps to Rs 121 cr, Business Standard
April 22
GSK Pharma to bring in rotavirus, cervical cancer vaccines, The Hindu Busines Line
April 15
GSK Pharma inks deal with Daiichi Sankyo, The Hindu Business Line
February 23
GSK Pharma gains from vaccines, priority products, The Hindu Business Line
February 22
Glaxo ready to roll out four drugs in 4 months, Business Standard
February 2
GSK Pharma launches two new vaccines, The Hindu Business Line
January 20
Wait for it to react, The Hindu Business Line
January 4
Regulator clears first gastroenteritis vaccine, Mint
December 28
GSK lines up two patented vaccines for India launch, Mint
December 19
GSK sets sight on local drug brand, The Economic Times
November 10
GSK's strategy depends on market dynamics, The Hindu Business Line
November 7
GSK set to launch cancer drug Tykerb in India, The Hindu Business Line
July 27
Thermo Fisher Scientific acquires Qualigens Fine Chemicals, The Economic Times
July 27
GSK Pharma Exits Fine Chemicals Biz, The Hindu Business Line
April 9
For pharma companies, it is about making the right choices. Businessworld
April 4
Ranbaxy, GSK join hands, The Times of India
March 31
Glaxo Set For Cardiovascular Drug Launch Soon, The Hindu Business Line
March 29
TCS to manage GSK data, Times of India
March 28
GSK, TCS to set up global centre in Mumbai, The Economic Times
March 22
GlaxoSmithKline opens new medicinal chemistry laboratory at Singapore, Pharmabiz
March 15
GSK to Seek Drug Controller nod for Breast Cancer Drug, The Hindu Business Line
February 7
Glaxo, Ranbaxy expand R&D deal, The Economic Times
February 7
GlaxoSmithKline, Ranbaxy To Expand R&d Alliance, The Hindu Business Line
January 27
ITeS - India No. 2 destination for clinical trial outsourcing, The Economic Times
Back to top
CSR in India
Our stated mission statement is To lend a helping hand to the less fortunate in our society through the support of women, children and the aged in the areas of health and education. Implementing this philosophy in spirit, we make a positive contribution to the communities in which we operate, and invest in health and education programs and partnerships that aim to bring sustainable improvements to under-served people.
This section may contains information in several formats:
To download PDF files you will need Adobe Reader . If you do not have it installed, it is available free from the Adobe website. PDF links on this site open in a new window.
For audio-visual content you can use either Windows Media Player or Real Player , which can be installed free from their respective websites.
